-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Ayala Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q4 2023.
- Ayala Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $103K, a 37.3% increase year-over-year.
- Ayala Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$3.91M, a 770% decline year-over-year.
- Ayala Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$3.91M, a 770% decline from 2022.
- Ayala Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $584K, a 1068% increase from 2021.
- Ayala Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $50K, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)